Table 1 Clinicopathologic characteristics of gastrointestinal tumors (GISTs)
Characteristic | Frequency (%) |
|---|---|
Gender | |
Male | 32 (61.5%) |
Female | 20 (38.51%) |
Age (years) | |
Mean | 53.4 (18–71 years) |
Age groups (years) | |
< 30 | 3 (5.8%) |
31–50 | 18 (34.61%) |
> 50 | 31 (59.6%) |
Primary/metastatic | |
Primary | 48 (92.3%) |
Metastasis | 4 (7.74%) |
Site | |
Stomach | 30 (57.7%) |
Small intestine | 10 (19.2%) |
Large intestine | 08 (15.4%) |
Liver | 04 (7.7%) |
Size (cm) | |
Mean | 9.4 (2–16) |
Size groups (cm) | |
< 2 | 1 (1.9%) |
2–5 | 6 (11.5%) |
5–10 | 20 (35.5%) |
> 10 | 22 (42.3%) |
Morphology | |
Spindle | 39 (75%) |
Eptheloid | 4 (7.5%) |
Mixed | 9 (17.3%) |
Grade (mitotic activity) | |
Low grade (< 5/50HPFs) | 23 (44.2%) |
High grade (> 5/50HPFs) | 29 (55.8%) |
Necrosis | |
Present | 10 (19.2%) |
Absent | 42 (80.8%) |
Prognostic groups | |
Very low risk | 5 (9.63%) |
Low risk | 11 (21.2%) |
Moderate risk | 5 (9.6%) |
High risk | 28 (53.8%) |